Panic disorder and subthreshold panic in the light of comorbidity: a follow-up study

被引:11
作者
Oral, Elif [1 ]
Aydin, Nazan [1 ]
Gulec, Mustafa [1 ]
Oral, Meltem [1 ]
机构
[1] Ataturk Univ, Dept Psychiat, Fac Med, TR-25240 Erzurum, Turkey
关键词
EXTENDED-RELEASE CAPSULES; DSM-IV DISORDERS; ANXIETY DISORDERS; DOUBLE-BLIND; EARLY INTERVENTION; AGORAPHOBIA; POPULATION; PREVALENCE; PREVENTION; EPIDEMIOLOGY;
D O I
10.1016/j.comppsych.2012.01.009
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Especially in the presence of agoraphobia and comorbid conditions, panic disorder causes significant impairment in life quality. Although there are several studies about epidemiology and clinical features, subthreshold symptoms and courses of comorbidity have not been studied sufficiently in panic disorder. The current study assessed the courses of panic disorder and subthreshold panic symptoms in consideration of the major and subthreshold comorbid conditions. Patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-diagnosed panic disorder were assessed using the panic disorder follow-up questionnaire, Panic and Agoraphobia Scale, Hamilton Depression Rating Scale, and State-Trait Anxiety Inventory. Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders was used to determine comorbidity, and all participants were received to 1-year follow-up. Comorbidity assessment showed that the threshold comorbidity decreased, while the subthreshold comorbidity increased at 1-year follow-up. Panic disorder symptom severity was decreased, but subthreshold panic symptoms continued to be present within the course of the illness. Presence of agoraphobia and duration of disease were significantly related with higher Panic and Agoraphobia Scale scores in the second assessment, and these relationships were independent from the treatment process. Even if the comorbidity and the severity of panic decrease with treatment, subthreshold panic and comorbid symptoms may still resist in panic disorder. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:988 / 994
页数:7
相关论文
共 58 条
[21]  
First M.B., 2001, Structured Clinical Interview for DSM-IV Axis I Disorders
[22]   Autonomic balance revisited: Panic anxiety and heart rate variability [J].
Friedman, BH ;
Thayer, JF .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1998, 44 (01) :133-151
[23]   Prevention of panic disorder [J].
Gardenswartz, CA ;
Craske, MG .
BEHAVIOR THERAPY, 2001, 32 (04) :725-737
[24]   The epidemiology of panic disorder and agoraphobia in Europe [J].
Goodwin, RD ;
Faravelli, C ;
Rosi, S ;
Cosci, F ;
Truglia, E ;
de Graaf, R ;
Wittchen, HU .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (04) :435-443
[25]  
HOEHNSARIC R, 1993, J CLIN PSYCHOPHARM, V13, P321
[26]   Prevalence, co-morbidity and correlates of mental disorders in the general population:: results from the German Health Interview and Examination Survey (GHS) [J].
Jacobi, F ;
Wittchen, HU ;
Hölting, C ;
Höfler, M ;
Pfister, H ;
Müller, N ;
Lieb, R .
PSYCHOLOGICAL MEDICINE, 2004, 34 (04) :597-611
[27]  
KATON WJ, 1990, J CLIN PSYCHIAT, V51, P27
[28]   LONG-TERM FOLLOW-UP AFTER A DRUG TRIAL FOR PANIC DISORDER [J].
KATSCHNIG, H ;
AMERING, M ;
STOLK, JM ;
KLERMAN, GL ;
BALLENGER, JC ;
BRIGGS, A ;
BULLER, R ;
CASSANO, G ;
GARVEY, M ;
ROTH, M ;
SOLYOM, C .
BRITISH JOURNAL OF PSYCHIATRY, 1995, 167 :487-494
[29]   The long-term course of panic disorder and its predictors [J].
Katschnig, H ;
Amering, M .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (06) :6S-11S
[30]   COURSE AND OUTCOME IN PANIC DISORDER [J].
KELLER, MB ;
HANKS, DL .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1993, 17 (04) :551-570